Pfizer Inc (PFE)
Return on assets (ROA)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 2,119,000 | 31,372,000 | 21,979,000 | 9,159,000 | 16,026,000 |
| Total assets | US$ in thousands | 227,000,000 | 197,000,000 | 181,000,000 | 154,229,000 | 167,594,000 |
| ROA | 0.93% | 15.92% | 12.14% | 5.94% | 9.56% |
December 31, 2023 calculation
ROA = Net income ÷ Total assets
= $2,119,000K ÷ $227,000,000K
= 0.93%
Pfizer Inc.'s return on assets (ROA) has shown significant fluctuations over the past five years, with a downward trend from 2019 to 2020. The ROA stood at 9.71% in 2019, exhibiting a solid performance, but then decreased to 6.23% in 2020. However, there was a notable recovery in 2021, with the ROA climbing to 12.11%. This positive momentum continued into 2022, where the ROA surged to 15.91%, indicating a strong performance.
The most recent data for 2023 shows a ROA of 0.94%, a substantial decrease compared to the previous year's exceptionally high performance. This significant drop in ROA in 2023 may warrant further investigation into what factors contributed to the decline in profitability relative to the assets employed. It is crucial for stakeholders and analysts to delve deeper into the financial circumstances of Pfizer Inc. to better understand the causes behind this recent decline in return on assets and assess the implications for the company's overall financial health.
Peer comparison
Dec 31, 2023